42 related articles for article (PubMed ID: 8342076)
21. New preparative regimens with diaziquone or cytarabine in combination with busulfan and cyclophosphamide.
Devine SM; Geller RB; Holland HK; Wingard JR; Saral R
Semin Oncol; 1993 Aug; 20(4 Suppl 4):56-63; quiz 64. PubMed ID: 8342077
[TBL] [Abstract][Full Text] [Related]
22. High-dose etoposide in allogeneic stem cell transplantation.
Bruserud O; Reikvam H; Kittang AO; Ahmed AB; Tvedt TH; Sjo M; Hatfield KJ
Cancer Chemother Pharmacol; 2012 Dec; 70(6):765-82. PubMed ID: 23053272
[TBL] [Abstract][Full Text] [Related]
23. The development of busulfan/cyclophosphamide preparative regimens.
Santos GW
Semin Oncol; 1993 Aug; 20(4 Suppl 4):12-6; quiz 17. PubMed ID: 8342070
[TBL] [Abstract][Full Text] [Related]
24. High-dose etoposide (VP-16)-containing preparatory regimens in allogeneic and autologous bone marrow transplantation for hematologic malignancies.
Blume KG; Forman SJ
Semin Oncol; 1992 Dec; 19(6 Suppl 13):63-6. PubMed ID: 1492228
[TBL] [Abstract][Full Text] [Related]
25. Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies.
Klingemann HG; Shepherd JD; Reece DE; Barnett MJ; Nantel SH; Sutherland HJ; Spinelli JJ; Phillips GL
Bone Marrow Transplant; 1994; 14 Suppl 4():S14-8. PubMed ID: 7728119
[No Abstract] [Full Text] [Related]
26. Are new conditioning regimens for transplants in acute myelogenous leukemia better?
Aurer I; Gale RP
Bone Marrow Transplant; 1991 Apr; 7(4):255-61. PubMed ID: 2070130
[TBL] [Abstract][Full Text] [Related]
27. Overview of the clinical relevance of autologous bone marrow transplantation.
Appelbaum FR; Buckner CD
Clin Haematol; 1986 Feb; 15(1):1-18. PubMed ID: 3516484
[No Abstract] [Full Text] [Related]
28. Etoposide in leukemia, lymphoma and bone marrow transplantation.
Stadtmauer EA; Cassileth PA; Gale RP
Leuk Res; 1989; 13(8):639-50. PubMed ID: 2677526
[TBL] [Abstract][Full Text] [Related]
29. Autologous marrow transplantation for Hodgkin's disease current techniques and prospects.
Ahmed T
Cancer Invest; 1990; 8(1):99-106. PubMed ID: 2190678
[TBL] [Abstract][Full Text] [Related]
30. Developments in the treatment of acute leukemia in adults.
Volm MD; Tallman MS
Curr Opin Oncol; 1995 Jan; 7(1):28-35. PubMed ID: 7696360
[TBL] [Abstract][Full Text] [Related]
31. Salvage therapy for patients with lymphoma.
Armitage JO; Vose JM; Bierman PJ; Bishop MR
Semin Oncol; 1994 Aug; 21(4 Suppl 7):82-5. PubMed ID: 8091246
[TBL] [Abstract][Full Text] [Related]
32. Design of preparative regimens for stem cell transplantation in breast cancer.
Spitzer G; Adkins D; Dunphy F; Petruska P; Spencer V; Velasquez W
Breast Cancer Res Treat; 1993; 26 Suppl():S3-9. PubMed ID: 8400330
[TBL] [Abstract][Full Text] [Related]
33. High dose chemotherapy in solid tumours in adults.
Souhami R; Peters W
Clin Haematol; 1986 Feb; 15(1):219-34. PubMed ID: 3009066
[TBL] [Abstract][Full Text] [Related]
34. Treatment options for recurrent lymphomas.
Fisher RI; Stiff PJ
Semin Oncol; 1990 Apr; 17(2 Suppl 4):63-7. PubMed ID: 1692161
[TBL] [Abstract][Full Text] [Related]
35. Preparative regimens: chemotherapy versus chemoradiotherapy. A historical perspective.
Santos GW
Ann N Y Acad Sci; 1995 Dec; 770():1-7. PubMed ID: 8597352
[No Abstract] [Full Text] [Related]
36. Bone marrow metastasis in astrocytic gliomata.
Hsu E; Keene D; Ventureyra E; Matzinger MA; Jimenez C; Wang HS; Grimard L
J Neurooncol; 1998 May; 37(3):285-93. PubMed ID: 9524086
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow transplantation for malignant lymphoma.
Appelbaum FR; Thomas ED
Eur J Cancer Clin Oncol; 1987 Mar; 23(3):263-6. PubMed ID: 3297717
[No Abstract] [Full Text] [Related]
38. Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies.
Crilley P; Lazarus H; Topolsky D; Ciobanu N; Creger RJ; Fox RM; Bulova SI; Shina DC; Gucalp R; Cooper BW
Semin Oncol; 1993 Aug; 20(4 Suppl 4):50-4; quiz 55. PubMed ID: 8342076
[TBL] [Abstract][Full Text] [Related]
39. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).
Copelan EA; Biggs JC; Szer J; Thompson JM; Crilley P; Brodsky I; Klein JL; Kapoor N; Harman GS; Avalos BR
Semin Oncol; 1993 Aug; 20(4 Suppl 4):33-8; quiz 39. PubMed ID: 8342074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
